ChartRow logo
Share this page
KYMR
$104.78-3.11%
as of close, Oct 16, 2026
☾ AH $104.78 -3.11%
PeersMRNALLYMDTUNHJNJTMO

Kymera Therapeutics Inc. trailing returns

How Kymera Therapeutics Inc. (KYMR) has performed over the last day, week, month and year, over 5 years, and since inception, through October 16, 2026 — price return and dividends side by side, with the worst drop inside each window.

Trailing returns by period#

To 2026-10-16. Price return + dividends = total return. Per year (CAGR) for windows of a year or more, with the cumulative total return beneath. Worst drop: the deepest fall in the price from a high inside the window, and when it bottomed.

PeriodPriceDivsTotalWorst drop
1 day-3.1%+0.0%-3.1%—
5 days-6.8%+0.0%-6.8%-6.8%Oct 16
1 month-9.9%+0.0%-9.9%-14.2%Oct 16
YTD+34.7%+0.0%+34.7%-25.0%Jun 2
1 year+73.3%+0.0%+73.3%-27.7%Jan 2026
5 years+12.9%+0.0%+12.9%+83.2%-83.3%Oct 2023
Since inception (2020)+20.5%+0.0%+20.5%+215.0%-87.5%Oct 2023

Growth of KYMR#

Actual level with dividends reinvested (solid); dashed lines are each window's constant-rate path from start to today.

  • 5 years+12.9%/year · +83.2%

Methodology#

Trailing returns measure from the closest close about N years before the latest close (2026-10-16). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Price return is the change in KYMR's closing price; total return reinvests dividends (from its split- and dividend-adjusted closes); the dividends column is the difference between the two. The worst drop is the largest fall in the closing price from a high to a later low inside the window, the way a drawdown is usually quoted. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.

FAQ#

What is Kymera Therapeutics Inc.'s return since inception?
Since 2020, Kymera Therapeutics Inc. (KYMR) has compounded at about +20.5% a year — +215.0% in total.

More on Kymera Therapeutics Inc.